Literature DB >> 28190597

Costs of colorectal cancer screening provision in CDC's Colorectal Cancer Control Program: Comparisons of colonoscopy and FOBT/FIT based screening.

Sujha Subramanian1, Florence K L Tangka2, Sonja Hoover3, Janet Royalty2, Amy DeGroff2, Djenaba Joseph2.   

Abstract

We assess annual costs of screening provision activities implemented by 23 of the Centers for Disease Control and Prevention's Colorectal Cancer Control Program (CRCCP) grantees and report differences in costs between colonoscopy and FOBT/FIT-based screening programs. We analysed annual cost data for the first three years of the CRCCP (July 2009-June 2011) for each screening provision activity and categorized them into clinical and non-clinical screening provision activities. The largest cost components for both colonoscopy and FOBT/FIT-based programs were screening and diagnostic services, program management, and data collection and tracking. During the first 3 years of the CRCCP, the average annual clinical cost for screening and diagnostic services per person served was $1150 for colonoscopy programs, compared to $304 for FIT/FOBT-based programs. Overall, FOBT/FIT-based programs appear to have slightly higher non-clinical costs per person served (average $1018; median $838) than colonoscopy programs (average $980; median $686). Colonoscopy-based CRCCP programs have higher clinical costs than FOBT/FIT-based programs during the 3-year study timeframe (translating into fewer people screened). Non-clinical costs for both approaches are similar and substantial. Future studies of the cost-effectiveness of colorectal cancer screening initiatives should consider both clinical and non-clinical costs.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Activity-based costing; Colorectal cancer screening; Economic evaluation; Screening cost

Mesh:

Year:  2017        PMID: 28190597      PMCID: PMC5863533          DOI: 10.1016/j.evalprogplan.2017.02.007

Source DB:  PubMed          Journal:  Eval Program Plann        ISSN: 0149-7189


  19 in total

Review 1.  Cutting cost and increasing access to colorectal cancer screening: another approach to following the guidelines.

Authors:  Judith A Fisher; Christopher Fikry; Andrea B Troxel
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-01       Impact factor: 4.254

Review 2.  Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force.

Authors:  Evelyn P Whitlock; Jennifer S Lin; Elizabeth Liles; Tracy L Beil; Rongwei Fu
Journal:  Ann Intern Med       Date:  2008-10-06       Impact factor: 25.391

Review 3.  Cancer screening in the United States, 2015: a review of current American cancer society guidelines and current issues in cancer screening.

Authors:  Robert A Smith; Deana Manassaram-Baptiste; Durado Brooks; Mary Doroshenk; Stacey Fedewa; Debbie Saslow; Otis W Brawley; Richard Wender
Journal:  CA Cancer J Clin       Date:  2015-01-08       Impact factor: 508.702

4.  Costs of promoting cancer screening: Evidence from CDC's Colorectal Cancer Control Program (CRCCP).

Authors:  Florence K L Tangka; Sujha Subramanian; Sonja Hoover; Janet Royalty; Kristy Joseph; Amy DeGroff; Djenaba Joseph; Sajal Chattopadhyay
Journal:  Eval Program Plann       Date:  2016-12-12

5.  Importance of implementation economics for program planning-evaluation of CDC's colorectal cancer control program.

Authors:  Florence K L Tangka; Sujha Subramanian
Journal:  Eval Program Plann       Date:  2016-11-24

6.  Economies of scale in federally-funded state-organized public health programs: results from the National Breast and Cervical Cancer Early Detection Programs.

Authors:  Justin G Trogdon; Donatus U Ekwueme; Sujha Subramanian; Wesley Crouse
Journal:  Health Care Manag Sci       Date:  2013-12-11

7.  Cost of services provided by the National Breast and Cervical Cancer Early Detection Program.

Authors:  Donatus U Ekwueme; Sujha Subramanian; Justin G Trogdon; Jacqueline W Miller; Janet E Royalty; Chunyu Li; Gery P Guy; Wesley Crouse; Hope Thompson; James G Gardner
Journal:  Cancer       Date:  2014-08-15       Impact factor: 6.860

8.  Costs of planning and implementing the CDC's Colorectal Cancer Screening Demonstration Program.

Authors:  Sujha Subramanian; Florence K L Tangka; Sonja Hoover; Maggie C Beebe; Amy DeGroff; Janet Royalty; Laura C Seeff
Journal:  Cancer       Date:  2013-08-01       Impact factor: 6.860

9.  American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected].

Authors:  Douglas K Rex; David A Johnson; Joseph C Anderson; Phillip S Schoenfeld; Carol A Burke; John M Inadomi
Journal:  Am J Gastroenterol       Date:  2009-02-24       Impact factor: 10.864

10.  Cancer screening test use - United States, 2013.

Authors:  Susan A Sabatino; Mary C White; Trevor D Thompson; Carrie N Klabunde
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-05-08       Impact factor: 17.586

View more
  14 in total

1.  Primary care visit use after positive fecal immunochemical test for colorectal cancer screening.

Authors:  Grace Clarke Hillyer; Christopher D Jensen; Wei K Zhao; Alfred I Neugut; Benjamin Lebwohl; Jasmin A Tiro; Lawrence H Kushi; Douglas A Corley
Journal:  Cancer       Date:  2017-06-16       Impact factor: 6.860

2.  Managed Health Care and Utilization of Fecal Occult Blood Testing for Colorectal Cancer Screening: a National Database Study.

Authors:  Daniel Bushyhead; Paul Fishman
Journal:  J Gen Intern Med       Date:  2020-01       Impact factor: 5.128

3.  Importance of implementation economics for program planning-evaluation of CDC's colorectal cancer control program.

Authors:  Florence K L Tangka; Sujha Subramanian
Journal:  Eval Program Plann       Date:  2016-11-24

4.  Economic assessment of patient navigation to colonoscopy-based colorectal cancer screening in the real-world setting at the University of Chicago Medical Center.

Authors:  Karen E Kim; Fornessa Randal; Matt Johnson; Michael Quinn; Chieko Maene; Sonja Hoover; Valerie Richmond-Reese; Florence K L Tangka; Djenaba A Joseph; Sujha Subramanian
Journal:  Cancer       Date:  2018-10-25       Impact factor: 6.860

5.  Identifying optimal approaches to implement colorectal cancer screening through participation in a learning laboratory.

Authors:  Florence K L Tangka; Sujha Subramanian; Amy S DeGroff; Faye L Wong; Lisa C Richardson
Journal:  Cancer       Date:  2018-10-25       Impact factor: 6.860

6.  Cost and Effectiveness of Reminders to Promote Colorectal Cancer Screening Uptake in Rural Federally Qualified Health Centers in West Virginia.

Authors:  Mary Ellen Conn; Stephenie Kennedy-Rea; Sujha Subramanian; Adam Baus; Sonja Hoover; Cheryl Cunningham; Florence K L Tangka
Journal:  Health Promot Pract       Date:  2020-09-29

7.  Can Cost-effectiveness Analysis Inform Genotype-Guided Aspirin Use for Primary Colorectal Cancer Prevention?

Authors:  Diana I Brixner; David D Stenehjem; Cornelia M Ulrich; Eman Biltaji; Brandon Walker; Trang H Au; Zachary Rivers; Jennifer Ose; Christopher I Li
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-04-13       Impact factor: 4.254

8.  Increasing Colorectal Cancer Screening in Health Care Systems Using Evidence-Based Interventions.

Authors:  Amy DeGroff; Krishna Sharma; Anamika Satsangi; Kristy Kenney; Djenaba Joseph; Katherine Ross; Steven Leadbetter; William Helsel; William Kammerer; Rick Firth; Tanner Rockwell; William Short; Florence Tangka; Faye Wong; Lisa Richardson
Journal:  Prev Chronic Dis       Date:  2018-08-09       Impact factor: 2.830

9.  Comparison of Program Resources Required for Colonoscopy and Fecal Screening: Findings From 5 Years of the Colorectal Cancer Control Program.

Authors:  Sujha Subramanian; Florence K L Tangka; Sonja Hoover; Maggie Cole-Beebe; Djenaba Joseph; Amy DeGroff
Journal:  Prev Chronic Dis       Date:  2019-04-25       Impact factor: 2.830

Review 10.  Economic evaluation of patient navigation programs in colorectal cancer care, a systematic review.

Authors:  Chloé Gervès-Pinquié; Anne Girault; Serena Phillips; Sarah Raskin; Mandi Pratt-Chapman
Journal:  Health Econ Rev       Date:  2018-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.